| Literature DB >> 35888114 |
Naima Mammate1, Fatima Ezzahra El Oumari1, Hamada Imtara2, Salim Belchkar1, Anissa Lahrichi3, Ali S Alqahtani4, Omar M Noman4, Mahmoud Tarayrah5, Tarik Sqalli Houssaini1.
Abstract
The plant Saussurea costus (Falc) Lipsch has many biological activities and a strong curative and preventive power against a variety of diseases including cancer, diabetes, and hemorrhoids. In the current study, phytochemical screening was carried out as well as an investigation of the antilithiatic and antioxidant activities of aqueous and ethanolic extracts of this plant. The results showed that aqueous and ethanolic extracts were effective in reducing cystine stone mass and that the aqueous extract of Saussurea costus (Falc) Lipsch had the highest percentage of dissolution (6.756 ± 1.024) (p < 0.05). A turbidimetric method and a crystallization test were used to evaluate the antilithiatic activity of an aqueous and ethanolic extract of this plant on calcium oxalate crystallization. The results of these methods revealed that the ethanolic extract of this plant has a significant inhibitory effect on calcium oxalate crystallization, with a percentage inhibition of (91.017 ± 0.299) (p < 0.05) for a concentration of 2 mg mL-1. The DPPH method revealed that the ethanolic extract of Saussurea costus (Falc) Lipsch with a concentration of (IC50 = 0.12325 mg mL-1) had the highest IC50, whereas the FRAP method revealed that the aqueous extract of Saussurea costus (Falc) Lipsch with a concentration of 300 µg mL-1 has the most significant reducing power with (OD = 0.56 ± 0.05). These findings indicate that aqueous and ethanolic extracts of Saussurea costus (Falc) Lipsch had a significant effect on whewellite and weddellite and a greater free radical scavenging effect but had no effect on cystine dissolution.Entities:
Keywords: FT-IR; Saussurea costus (Falc) Lipsch and SEM-EDX; calcium oxalate; cystine
Year: 2022 PMID: 35888114 PMCID: PMC9316092 DOI: 10.3390/life12071026
Source DB: PubMed Journal: Life (Basel) ISSN: 2075-1729
The results of the extraction yields of the plants.
| The Plants | The Extracts | The Yields% |
|---|---|---|
| Ethanolic extract | 18.79 ± 0.01 | |
| Aqueous extract | 28.41 ± 0.01 |
Results of the phytochemical screening.
| Sterols and Terpenes | Steroidal Heterosides | Flavonoids | Tannins | Quinones | Alkaloids | |
|---|---|---|---|---|---|---|
| Aqueous extract | + | - | - | + | + | + |
| Ethanolic extract | + | - | + | + | + | + |
+: a substance found in the extract. -: a substance not found in the extract.
The retention time (RT) and peak area (percent) of the different compounds that were found in an ethanolic extract of Saussurea costus that were analyzed by GC-MS.
| Chemical Constituents | Molecular Formula | RT (min) | Peak Area % | Molecular Weight |
|---|---|---|---|---|
| Dehydrocostuslactone | C15H18O2 | 30.41 | 49.68 | 230 |
| Saussurea lactone | C15H22O2 | 23.26 | 4.16 | 234 |
| Costunolide | C15H20O2 | 26.31 | 3.59 | 232 |
| Dihydrodehydrocostus lactone | C15H18O2 | 29.21 | 16.34 | 230 |
| Beta-costol | C15H24O | 25.55 | 2.74 | 220 |
| (+)-Isovalencenol | C15H24O | 31.71 | 2.52 | 220 |
| Caryophyllene oxide | C15H24O | 27.02 | 11.03 | 220 |
| (+)-Isovalencen | C15H24O | 31.71 | 2.52 | 220 |
| Linoleic acid, methyl ester | C19H34O2 | 32.1 | 2.15 | 294 |
| 9-Octadecenoic acid, methyl ester | C19H36O2 | 32.22 | 1.54 | 296 |
| Aristol-1(10)-en-9-ol | C15H24O | 25.67 | 1.41 | 220 |
| Hexadecanoic acid,methyl ester | C17H34O2 | 28.89 | 0.85 | 270 |
| Valerenol | C15H24O | 30.64 | 0.46 | 220 |
| Reynosin | C15H20O3 | 31.05 | 0.39 | 248 |
| Beta-caryophyllene oxide | C15H24O | 21.4 | 0.38 | 220 |
| Linolein, 2-mono- | C21H38O4 | 19.07 | 0.38 | 354 |
| 10-Heptadecen-8-ynoic acid, methyl ester, (E)- | C18H30O2 | 32.44 | 0.25 | 278 |
| Octadecanoic acid, methyl ester | C19H38O2 | 32.71 | 0.24 | 298 |
| 16-Methyloxacyclohexadeca-3,5-dien-2-one | C16H26O2 | 32.81 | 0.24 | 250 |
| Santamarine | C15H20O3 | 28.43 | 0.18 | 248 |
| Glycidyl oleate | C21H38O3 | 33.39 | 0.22 | 338 |
| Farnesene epoxide, E- | C15H24O | 33.49 | 0.17 | 220 |
| Eudesm-4(14)-en-11-ol | C15H26O | 20.62 | 0.16 | 222 |
| Trans-á-Ionone | C15H26O | 38.52 | 0.15 | 222 |
| Glycerin | C3H8O3 | 3.269 | 0.87 | 92 |
| Ethoxyacetaldehyde diethylacetal | C8H18O3 | 3.346 | 1.28 | 162 |
| 2-Furanmethanol | C5H6O2 | 3.631 | 0.28 | 98 |
| Methanamine, N-hydroxy-N-methyl- | C2H7NO | 4.234 | 2.31 | 61 |
| 2-hydroxy-2-Cyclopenten-1-one | C5H6O2 | 4.754 | 0.31 | 98 |
| 2,4-Dihydroxy-2,5-dimethyl-3(2H)-furan-3-one | C6H8O4 | 5.715 | 0.29 | 144 |
| 2,5-Hexanedione | C6H10O2 | 7.066 | 0.21 | 130 |
| Pentanoic acid,4-oxo- (Levulinic acid) | C5H8O3 | 7.154 | 0.11 | 116 |
| 2,5-Dimethyl-4-hydroxy-3(2H)-furanone (Furaneol) | C6H8O3 | 7.397 | 0.09 | 128 |
| Maltol | C6H6O3 | 7.845 | 0.73 | 126 |
| 4H-Pyran-4-one,2,3-dihydro-3,5-dihydroxy-6-methyl- | C6H8O4 | 9.209 | 1.14 | 144 |
| 5-Hydroxymethylfurfural | C6H6O3 | 11.033 | 2.15 | 126 |
| 1,2,3-propanetriol,1-acetate | C5H10O4 | 11.343 | 1.53 | 134 |
| Propanoic acid,3-(acetyloxy)-2-(hydroxymethyl)-,ethyl ester | C8H14O5 | 12.297 | 1.04 | 190 |
| 1,3-propanediol,2-(hydroxymethyl)-2-nitro- | C4H9NO5 | 15.686 | 11.05 | 151 |
| 11,11-Dimmethyl-spiro(2,9)dodeca-3,7-dien | C14H22 | 17.997 | 0.19 | 190 |
| 1,2,3,5-Cyclohexanetetrol, (1.alpha, 2.beta.3.alpha, 5.beta.)- | C6H12O4 | 18.585 | 0.76 | 148 |
| 9,12,15-octadecatrienoic acid,(z,z,z) | C18H30O2 | 19.174 | 2.49 | 278 |
| Androstan-17-one,3-ethyl-3-hydroxy-,(5.alpha)- | C12H34O2 | 19.255 | 3.01 | 210 |
| 2-(4a,8-Dimethyl-1,2,3,4,4a,5,6,7-octahydro-naphthalen-2- | C15H24 | 20.604 | 0.31 | 204 |
| Bicyclo(5.2.0)nonane,4-methylene-2,8,8-trimethyl-2-vinyl- | C15H24 | 20.677 | 0.32 | 204 |
| Andrographolide | C20H30O5 | 20.777 | 0.17 | 350 |
| Bicyclo(5.3.0)decane,2-methylene-5-(1-methylvinyl)-8- | C15H24 | 20.927 | 4.36 | 204 |
| Gamma.-guarjumenepoxide-(2) | C15H24O | 20.993 | 1.77 | 216 |
| 2(3H)-benzofuranone,6-ethenylhexahydro-6-methylene-7- | C15H20O2 | 21.855 | 3.88 | 232 |
| Alloaromadendrene | C15H24 | 22.237 | 1.36 | 204 |
| Pentadecanoic acid | C15H30O2 | 23.156 | 1.79 | 242 |
| 4,7,10,13,16,19-Docosahexaenoic acid, methyl ester | C23H34O2 | 23.227 | 3.18 | 342 |
| Cyclodecacyclotetradecene,14,15-didehydro- | C22H32 | 23.933 | 39.59 | 296 |
| Beta.-Guaiene | C15H24 | 25.734 | 1.21 | 204 |
| Isosteviol methyl ester | C21H32O3 | 25.863 | 3.97 | 332 |
| Bufa-20,22-dienolide,14,15-epoxy- | C24H34O2 | 26.180 | 5.91 | 354 |
| -Norlupan-28-oic acid,3-hyroxy-21- | C29H46O4 | 26.997 | 1.05 | 458 |
| Octadecanoic acid,2,3-dihydroxypropyl- | C21H42O4 | 28.511 | 0.41 | 358 |
| 9,12-Octadecadienoic acid (z,z)- | C18H32O2 | 29.991 | 0.34 | 280 |
| Pregnennolone | C21H32O2 | 30.631 | 0.21 | 316 |
| Spiro(5.5)undeca-1,8-diene,1,5,5,- | C15H24 | 31.009 | 0.33 | 204 |
The retention time (RT) and peak area (percent) of the different compounds that were found in an aqueous extract of Saussurea costus that were analyzed by GC-MS.
| Chemical Constituents | Molecular Formula | RT (min) | Peak Area % | Molecular Weight |
|---|---|---|---|---|
| 2-Cyclopenten-1-one,2-hydroxy- | C5H6O2 | 4.772 | 0.61 | 90 |
| 1-Dodecanol | C12H26O | 10.071 | 0.36 | 186 |
| 1,2,3-propanetriol,1-acetate | C5H10O4 | 11.401 | 1.16 | 134 |
| Cyclohexane,1-ethenyl-1-methyl-2,4-bis- | C15H24 | 14.314 | 0.17 | 204 |
| Caryophyllen | C15H24 | 14.918 | 0.15 | 204 |
| 3-Buten-2-one,4-(2,6,6-trimethyl-2-cyclo- | C13H20O | 15.000 | 0.18 | 192 |
| 1,3-propanediol,2-(hydroxymethyl)-2- | C4H9NO5 | 15.220 | 2.88 | 151 |
| 9,12,15-octadecatrienoic acid,(z,z,z)- | C18H30O2 | 19.178 | 3.47 | 270 |
| Cyclohexane,1,2-diethenyl-4-(1-methyle- | C13H20 | 19.256 | 3.12 | 176 |
| Alpha.-Guaiene | C15H24 | 20.928 | 4.17 | 204 |
| Delta.4-androstene-3.beta,17.beta.-diol | C19H30O2 | 20.993 | 1.88 | 290 |
| 2(3H)-benzofuranone,6-ethenythexhydroxy- | C15H20O2 | 21.842 | 4.42 | 232 |
| 4,7,10,13,16,19-Docosahexaenoic acid, methyl ester | C22H34O2 | 23.227 | 2.96 | 296 |
| Cyclodecacyclotetradecene,14,15-didehydroxy | C22H32 | 23.889 | 61.69 | 296 |
| 1,4-Methanocycloocta(d)pyridazine,1,4,4a- | C12H20N2 | 25.863 | 2.73 | 192 |
| 3-oxatricyclo(20.8.0.0(7,16))triaconta-1- | C29H42O | 26.178 | 3.49 | 406 |
| Octadecanoic acid,2,3-dihydroxypropyl- | C21H42O4 | 28.520 | 1.44 | 358 |
| Cholest-7-en-3-ol,4-methyl-,(3.beta, 4.alpha- | C28H48O | 31.285 | 5.10 | 400 |
Figure 1(A) Representative structures of the major metabolites that were identified in the ethanolic extract of the roots of Saussurea costus. (B) Representative structures of the main metabolites that were identified in the aqueous extract of the roots of Saussurea costus.
Figure 2Spectrum (FT-IR) of a cystine stone.
Figure 3Evolution of the effect of extracts as a function of time on the loss of cystine stone mass (%) during 6 weeks. (Each value represents the average of three trials ± SD). * p value < 0.05.
Figure 4Evolution of the effect of extract type as a function of time on pH (each value represents the average of three trials ± SD). ** p value < 0.01.
Figure 5(A) The surface of the crystals visualized by SEM which is coupled to EDX before any treatment (B) The surface of the crystals visualized by SEM which is coupled to EDX after treatment by citrate (C) The surface of the crystals visualized by SEM which is coupled to EDX after treatment by the solution containing the ethanolic extract of Saussurea costus (Falc) Lipsch (D) The surface of the crystals visualized by SEM which is coupled to EDX after treatment by the aqueous solution of NaCl 9 gL−1 (E) The surface of the crystals visualized by SEM which is coupled to EDX after treatment by the solution containing the aqueous extract of Saussurea costus (Falc) Lipsch.
Figure 6(A) Spectra of calcium oxalate, and (B) the effect of the extracts on the crystallization of calcium oxalate. * p value < 0.05, ** p value < 0.01.
The number of crystals in the presence of extracts of Saussurea costus (Falc) Lipsch and cystone solution.
| Concentration | Cystone Solution | ||
|---|---|---|---|
| 0.5 mg/mL | 1000 mm3 | 900 mm3 | 600 mm3 |
| 1 mg/mL | 700 mm3 | 400 mm3 | 300 mm3 |
| 2 mg/mL | 500 mm3 | 300 mm3 | 250 mm3 |
Figure 7Microscopic observation of crystals at different inhibitor concentrations.
Figure 8Antiradical activity (DPPH) of extracts (each value represents the average of three trials ± SD).
Figure 9Evaluation of antioxidant activity of extracts by FRAP method (each value represents the average of three trials ± SD). * p value <0.05, ** p value <0.01, *** p value <0.005.